Primer IDs (pIDs) are random oligonucleotide tags used in next-generation sequencing to identify sequences that originate from the same template. These tags are produced by degenerate primers during the reverse transcription of RNA molecules into cDNA. The use of pIDs helps to track the number of RNA molecules carried through amplification and sequencing, and allows resolution of inconsistencies between reads sharing a pID. Three potential issues complicate the above applications. First, multiple cDNAs may share a pID by chance; we found that while preventing any cDNAs from sharing a pID may be unfeasible, it is still practical to limit the number of these collisions. Secondly, a pID must be observed in at least three sequences to allow error correction; as such, pIDs observed only one or two times must be rejected. If the sequencing product contains copies from a high number of RT templates but produces few reads, our findings indicate that rejecting such pIDs will discard a great deal of data. Thirdly, the use of pIDs could influence amplification and sequencing. We examined the effects of several intrinsic and extrinsic factors on sequencing reads at both the individual and ensemble level.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4081055PMC
http://dx.doi.org/10.1093/nar/gku355DOI Listing

Publication Analysis

Top Keywords

next-generation sequencing
8
rna molecules
8
amplification sequencing
8
sharing pid
8
sequencing
6
pids
5
theoretical experimental
4
experimental assessment
4
assessment degenerate
4
degenerate primer
4

Similar Publications

A family with gallstone disease: defining inherited risk in the era of clinical genetic testing.

Intern Emerg Med

January 2025

Department of Gastroenterology, Hepatology and Transplant Medicine, Medical Faculty, University of Duisburg-Essen, Hufelandstraße 55, 45147, Essen, Germany.

Gallstones are among the most frequent hepatobiliary conditions. Although in most cases, they remain asymptomatic, they can cause complications and, in such cases, invasive treatments like endoscopic retrograde cholangiography (ERC) or cholecystectomy are required. Here, we present the results of genetic testing of a single family with a high incidence of symptomatic gallstones and cholestatic liver phenotypes.

View Article and Find Full Text PDF

Targeted Enrichment Sequencing Utilizing a Respiratory Pathogen Panel for Genomic Wastewater-Based Viral Epidemiology in Uruguay.

Food Environ Virol

January 2025

Laboratorio de Ecología Viral y Virus Zoonóticos, Unidad Académica de Bacteriología y Virología, Instituto de Higiene, Facultad de Medicina, Universidad de la República, Av. Alfredo Navarro 3051, 11600, Montevideo, Uruguay.

Human respiratory and enteric viruses are responsible for substantial morbidity and mortality worldwide. Wastewater-based epidemiology utilizing next-generation sequencing serves as an effective tool for monitoring viral circulation dynamics at the community level. However, these complex environmental samples are often laden with other microorganisms and host genomic material, which can hinder the sensitivity of viral detection.

View Article and Find Full Text PDF

Biomarkers.

Alzheimers Dement

December 2024

ADmit Therapeutics SL, Barcelona, Barcelona, Spain.

Background: Prediction of progression to Alzheimer's Disease Dementia (ADD) at the Mild Cognitive Impairment (MCI) stage is an unmet medical need. Mitochondrial dysfunction in Alzheimer's Disease at the brain and systemic level has been extensively described. Our previous studies showed an altered mtDNA methylation pattern throughout AD progression in human postmortem brains (Blanch et al.

View Article and Find Full Text PDF

Developing Topics.

Alzheimers Dement

December 2024

Brain Research Institute, Niigata University, Niigata, Niigata, Japan.

Background: The Alzheimer's disease treatment drug "Lecanemab" has been approved in the US, Japan, and China, and administration has begun in clinical treatment. Other anti-Aβ antibody drugs (e.g.

View Article and Find Full Text PDF

Background: To date, mutations in the MAPT (i.e., tau) gene within Alzheimer's disease (AD) patients are either benign or have an unclear effect on pathogenicity.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!